Association of CYP2D6*10 (c.100C>T) polymorphisms with clinical outcome of breast cancer after tamoxifen adjuvant endocrine therapy in Chinese population

about

The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis.Precision medicine: does ethnicity information complement genotype-based prescribing decisions?

P2860

Q45987663-78E46B8B-B7FC-4711-A0A1-76B709D9074A Q47566249-BA8A1551-0318-4D4B-BADB-70229B4086A5

P2860

Association of CYP2D6*10 (c.100C>T) polymorphisms with clinical outcome of breast cancer after tamoxifen adjuvant endocrine therapy in Chinese population

Item

http://www.wikidata.org/entity/Q37228037

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Association of CYP2D6*10 (c.10 ...... therapy in Chinese population

@en

Association of CYP2D6*10

@nl

type

Item

label

Association of CYP2D6*10 (c.10 ...... therapy in Chinese population

@en

Association of CYP2D6*10

@nl

prefLabel

Association of CYP2D6*10 (c.10 ...... therapy in Chinese population

@en

Association of CYP2D6*10

@nl

P1476

Association of CYP2D6*10 (c.10 ...... therapy in Chinese population

@en

P2093

Lei Lei

http://www.w3.org/2001/XMLSchema#string

Xian Wang

http://www.w3.org/2001/XMLSchema#string

Xiao-Dan Wu

http://www.w3.org/2001/XMLSchema#string

Xiao-Jia Wang

http://www.w3.org/2001/XMLSchema#string

Ya-Bin Zheng

http://www.w3.org/2001/XMLSchema#string

Zeng Wang

http://www.w3.org/2001/XMLSchema#string

Zhan-Hong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2016

Why do results conflict regarding the prognostic value of the methylation status in colon cancers? The role of the preservation method.

Genetic variation in the 3'-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance.

Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation.

Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen.

Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes.

Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes.

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

CYP2D6 genotype and tamoxifen response for breast cancer: a systematic review and meta-analysis.

Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.

P304

3585-3592

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27648149

http://www.w3.org/2001/XMLSchema#string

P932

5009411

http://www.w3.org/2001/XMLSchema#string

Association of CYP2D6*10 (c.100C>T) polymorphisms with clinical outcome of breast cancer after tamoxifen adjuvant endocrine therapy in Chinese population

about

P2860

P2860

Association of CYP2D6*10 (c.100C>T) polymorphisms with clinical outcome of breast cancer after tamoxifen adjuvant endocrine therapy in Chinese population

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P932